Ghost Tree Capital, LLC Axsome Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

$267 Million
Q3 2024

A detailed history of Ghost Tree Capital, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 135,000 shares of AXSM stock, worth $16.9 Million. This represents 4.54% of its overall portfolio holdings.

Number of Shares

135,000

Previous 150,000 10.0%

Holding current value

$16.9 Million

Previous $12.1 Million 0.45%

% of portfolio

4.54%

Previous 4.93%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$78.93 - $95.84 $1.18 Million - $1.44 Million	-15,000 Reduced 10.0%	135,000 $12.1 Million
Q2 2024 Aug 14, 2024	SELL	$65.72 - $80.5 $3.94 Million - $4.83 Million	-60,000 Reduced 28.57%	150,000 $12.1 Million
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $3.12 Million - $4.39 Million	45,000 Added 27.27%	210,000 $16.8 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $3.16 Million - $4.6 Million	55,000 Added 50.0%	165,000 $13.1 Million
Q2 2023 Aug 14, 2023	SELL	$58.41 - $90.35 $6.72 Million - $10.4 Million	-115,000 Reduced 51.11%	110,000 $7.9 Million
Q1 2023 May 15, 2023	SELL	$58.39 - $75.0 $583,900 - $750,000	-10,000 Reduced 4.26%	225,000 $13.9 Million
Q4 2022 Feb 14, 2023	SELL	$39.94 - $79.72 $2.6 Million - $5.18 Million	-65,000 Reduced 21.67%	235,000 $18.1 Million
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $2.7 Million - $5.24 Million	75,000 Added 33.33%	300,000 $13.4 Million
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $2.84 Million - $6.1 Million	130,500 Added 138.1%	225,000 $8.62 Million
Q1 2022 May 16, 2022	BUY	$23.7 - $41.39 $2.24 Million - $3.91 Million	94,500 New	94,500 $3.91 Million
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $6.83 Million - $8.58 Million	-100,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$49.87 - $98.69 $5.74 Million - $11.3 Million	-115,000 Reduced 53.49%	100,000 $8.23 Million
Q1 2020 May 15, 2020	BUY	$41.2 - $101.31 $618,000 - $1.52 Million	15,000 Added 7.5%	215,000 $12.6 Million
Q4 2019 Feb 14, 2020	SELL	$16.71 - $106.24 $7.94 Million - $50.5 Million	-475,000 Reduced 70.37%	200,000 $20.7 Million
Q3 2019 Nov 14, 2019	SELL	$20.24 - $29.16 $3.54 Million - $5.1 Million	-175,000 Reduced 20.59%	675,000 $13.7 Million
Q2 2019 Aug 14, 2019	BUY	$13.46 - $25.75 $7.27 Million - $13.9 Million	540,000 Added 174.19%	850,000 $21.9 Million
Q1 2019 May 15, 2019	BUY	$2.63 - $16.34 $815,300 - $5.07 Million	310,000 New	310,000 $4.41 Million

Others Institutions Holding AXSM

# of Institutions

351

Shares Held

36.3M

Call Options Held

1.77M

Put Options Held

1.16M

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $5.36B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Account

Ghost Tree Capital, LLC Axsome Therapeutics, Inc. Transaction History